You will master the most innovative techniques of Transcranial Magnetic Stimulation for nerve cells in the brain through this very complete program"

The pharmacological treatment of Master's Degree has become a profound object of debate. However, the World Health Organization considers that medication is a vital aspect in the treatment of illnesses such as psychosis. At the same time, physicians are obliged to keep up to date with the latest criteria for the use and contraindications of the most advanced and widespread products, as well as those of new development. For this reason, specialists often call for a thorough update to enable them to implement excellent practice and provide the best care for their patients. However, this is a complex task given the difficulty of reconciling work and personal life.

In order to support them in this task, TECH has developed a program dedicated to the influence of medication on the brain. Under the support of a distinguished teaching team, the syllabus will delve into Electroconvulsive Therapy and Transcranial Magnetic Stimulation procedures. In addition, the program will address in depth the dual pathology existing between Psychotic Disorders and substance use. In this line, the consumption of alcohol, opiates and other stimulants will be emphasized. The curriculum will also urge the main public institutions to become aware of this problem and to carry out changes in the policy sector.

It is worth noting that the methodology of this program reinforces its innovative character, TECH offers a 100% online educational environment, tailored to the needs of busy professionals seeking to advance their careers. In addition, it will employ the  Relearning methodology, based on the repetition of key concepts to fix knowledge and facilitate learning. In this way, the combination of flexibility and a robust pedagogical approach makes it highly accessible. In addition, students will enter the a library full of multimedia resources in different audiovisual formats (such as interactive summaries and infographics) to make learning dynamic.

Analyze Refractory Psychotic Disorders through the contents provided by TECH, the best digital university in the world according to Forbes"

This Master's Degree in Psychotic Disorders contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical cases presented by experts in Psychology and Psychotic Disorders
• The graphic, schematic, and practical contents which provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

After this university degree, you will be able to detect cases of Late Onset Schizophrenia and apply the most effective therapeutic procedures"

The program’s teaching staff includes professionals from the sector who contribute their work experience to this program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the academic year For this purpose, the students will be assisted by an innovative interactive video system created by renowned and experienced experts.

Keep up to date with scientific advances in delusional disorder with this innovative program"

TECH guarantees flexibility of study through its 100% online format, which adapts to your professional schedule"

This syllabus is designed by a first class teaching staff, which will provide a correct diagnostic approach to Psychotic Disorders. In this line, the syllabus will delve into the new contributions to this field by prestigious authors such as Emil Kraepelin. Likewise, the didactic materials will address in detail the neurobiological aspects of psychosis in different stages of life so that students become aware of the risk factors. The itinerary will also provide family approach strategies in schizophrenia, while delving into the consequences of substance abuse (especially cannabis).

With the Relearning system you will integrate the concepts in a natural and progressive way. Forget about memorizing!”

Module 1. Relevant Aspects of the Psychotic Spectrum

1.1. The Psychotic Spectrum within mental disorders in Mental Disorders
1.2. Differentiation between Hallucination, Delusion, Delirium and Illusion

1.2.1. Classification
1.2.2. Differential Aspects at the Clinical Level

1.3. Current Classification of Psychotic Disorders in DSM-5
1.4. Modifications of the DSM-5 Regarding Previous Editions
1.5. Current Classification of Psychotic Disorders in ICD-11
1.6. Modifications of the ICD-11 Regarding Previous Editions
1.7. Emil Kraepelin and Kurt Schneider

1.7.1. Contribution to Psychotic Entities

1.8. Psychosis

1.8.1. Conceptualization in History

1.9. Freud, Contributions to Psychotic Nosology

1.9.1. Freud and Psychoanalysis

1.10. New Authors of the 21st Century in Psychotic Entities:

1.10.1. Contributions

Module 2. Biological Principles of Schizophrenia and Other Psychotic Disorders

2.1. The Neurobiology of Psychosis

2.1.1. The Brain and Psychosis

2.2. Genetic Aspects in Psychotic Disorders
2.3. Neuroendocrinological Bases in Psychotic Disorders
2.4. Role of Immunology in Psychotic Disorders
2.5. Influence of Inflammatory Factors in the Psychotic Spectrum
2.6. Neurobiological Aspects of Psychosis in the Different Stages of Life

2.6.1. Children and Adolescents
2.6.2. Adult
2.6.3. Elderly

2.7. Etiopathogenesis of Psychotic Disorders and its Influence on the Evolution of the Disorder

2.7.1. Risk Factors
2.7.2. Protective Factors

2.8. Neuroimaging in Psychosis
2.9. Approach to Refractory Psychotic Disorders
2.10. Current Positioning of Psychotic Entities in the Biological Plane

2.10.1. Scientific Developments

Module 3. Stages of Schizophrenia Throughout History

3.1. Origin of Schizophrenia

3.1.1. The Evolution of Schizophrenia up to the Present Day
3.2.1. Eugen Bleuler and the Onset of Schizophrenia

3.2. Schizophrenia and its Clinical Forms

3.2.1. Differential Clinical Features
3.2.2. Epidemiology

3.3. Late-Onset Schizophrenia

3.3.1. Clinical Form
3.3.2. Prognosis

3.4. Diagnostic Approach and Differential Diagnosis
3.5. Prognosis and Evolution

3.5.1. Changes in the Paradigm of the Schizophrenia Patient

3.6. Pharmacological Approach

3.6.1. New Pharmacological Proposals

3.7. Psychotherapeutic Intervention: Modalities and New Developments
3.8. Gender Differences

3.8.1. Quality of Life and Limitations

3.9. The Rehabilitative Stage in Schizophrenia
3.10. Strategies for Family Approach in Schizophrenia

Module 4. Delusional Disorder

4.1. Current DSM-V Classification and Changes from Other Editions
4.2. The Different Connotations of Delusional Disorder up to the 21st Century

4.2.1. Epidemiology and Current Figures

4.3. Clinical Features of Delusional Disorder

4.3.1. Classification of the Different Subtypes of Delusional Disorders

4.4. Diagnostic Modalities in Delusional Disorder
4.5. Evolution of this Disorder

4.5.1. Prognosis According to Age Ranges

4.6. Vital Repercussion and Quality of Life of Patients with Delusional Disorder
4.7. Pharmacological Treatment Proposals

4.7.1. The Patient's Awareness of Illness

4.8. The Psychotherapeutic Approach and Rehabilitation Strategies
4.9. Delusional Disorder up to at Different Stages of Life
4.10. Scientific Advances in Delusional Disorder

4.10.1. Studies and Current Situation

Module 5. Acute and Transitory Psychotic Disorder

5.1. Conceptualization and Nosological Changes up to the Present Day
5.2. Epidemiology and Current Situation
5.3. Epidemiology and Current Situation
5.4. Diagnosis and Differential Diagnosis
5.5. Course and Prognosis

5.5.1. Risk Factors and Protection in its Evolution

5.6. Gender and its Different Presentations in this Psychotic Entity
5.7. Influence of Substance use in its Onset and Development

5.7.1. Studies and Expert Voices on the Subject

5.8. Acute Psychotic Disorder in Adolescents

5.8.1. Connotations and Future Repercussions

5.9. Pharmacological Approach

5.9.1. Impact of Treatment in the Short, Medium and Long-Term

5.10. Psychotherapeutic Approach

5.10.1. Relevant Aspects in New Approaches

Module 6. Other Psychotic Entities

6.1. Schizoaffective Disorder (SAD) and its Evolution in the Classification up to DSM-5

6.1.1. Etiopathogenesis of SAD
6.1.2. Epidemiology

6.2. SAD: Clinical Features and Evolution
6.3. Diagnosis and Differential Diagnosis of SAD
6.4. Approach to SAD

6.4.1. Pharmacological
6.4.2. Psychotherapeutic
6.4.3. Prognosis

6.5. Schizophreniform Disorder

6.5.1. Epidemiology
6.5.2. Clinical Aspects and Diagnosis

6.6. Evolution of Schizophreniform Disorder

6.6.1. Prognosis

6.7. Treatment of Schizophreniform Disorder

6.7.1. Pharmacological
6.7.2. Psychotherapeutic Aspects

6.8. Catatonia

6.8.1. Etiological Factors
6.8.2. Clinical Manifestations

6.9. Diagnosis of Catatonia

6.9.1. Differential Diagnosis of Catatonia

6.10. Evolution of Catatonia

6.10.1. Prognosis of Catatonia

Module 7. Special Considerations in the Approach and Treatment of Psychotic Disorders

7.1. Pharmacological Treatment or not of Psychotic Disorders

7.1.1. A Difficult Debate to Close

7.2. Changes in Pharmacological Treatment up to the Present Day

7.2.1. The Abandonment of Certain Drugs

7.3. Antipsychotics and their Influence on the Patient's Quality of Life

7.3.1. Factors that Determine Correct Adherence

7.4. Other Pharmacological Modalities Used in Psychotic Disorders
7.5. Pharmacological Developments

7.5.1. New and Relevant Studies

7.6. Influence of Medication on the Brain

7.6.1. Responses through Neuroimaging

7.7. Suicide in Psychotic Disorders

7.7.1. Current Figures and Special Considerations
7.7.2. Approach

7.8. Electroconvulsive Therapy (ECT) and its use in Psychotic Disorders

7.8.1. Indications in the Psychotic Spectrum

7.9. Transcranial Magnetic Stimulation (TMS) and Psychotic Disorders

7.9.1. Indications in the Psychotic Spectrum

7.10. Conduction and Psychotropic Drugs in Psychotic Disorders

7.10.1. Legal Aspects

Module 8. Psychotic Disorders and Substance Use: Dual Pathology

8.1. Dual Pathology

8.1.1. Conceptualization and Evolution of the Concept

8.2. Cannabis and Psychosis

8.2.1. Psychopathological Characteristics
8.2.2. Current Data

8.3. Excitants and Psychosis

8.3.1. Psychopathological Characteristics

8.4. Opiates and Psychosis

8.4.1. Psychopathological Characteristics
8.4.2. Current Problem of its Use

8.5. Alcohol and Psychosis

8.5.1. Main Clinical Framework

8.6. Comorbidities in Substance Use
8.7. The Legal Framework in Dual Pathology

8.7.1. Current Relevant Aspects
8.7.2. Legal or Illegal

8.8. Prognosis and Evolution in Psychotic Disorder with Substance Abuse
8.9. Pharmacological Approach and New Aspects
8.10. Psychotherapeutic Approach and Rehabilitation

8.10.1. Family Dynamics

Module 9. Stigma and Quality of Life in Psychotic Disorders

9.1. Mental Disorder

9.1.1. Evolution of the Connotation of Mental Illness up to the Present

9.2. Stigma and its Meaning in Patients with Psychotic Disorder
9.3. Life with a Psychotic Disorder

9.3.1. Lifestyle and Limitations

9.4. Economic and Occupational Repercussions of Psychotic Disorders
9.5. Impact of the Disease on the Quality of Life and Life Goals
9.6. Social Work

9.6.1. Treatment Devices in Today's Society for the Approach of Psychotic Disorders

9.7. Coping Strategies and Skills in Psychotic Disorders

9.7.1. At the Individual Level
9.7.2. At the Family Level

9.8. Involvement of Institutions in Mental Health: Changes in the Policy Sector
9.9. Rehabilitation and Current Lines in Social Intervention in Patients with Psychotic Disorders
9.10. The Psychotic Patient's Family and Current Working Models

9.10.1. Coping with Psychotic Disorders in Today's Society

Module 10. Psychotic Disorders Today

10.1. The Psychotic Entity and its Shift of Focus in the Social Paradigm
10.2. Gender Perspective in Psychotic Disorders

10.2.1. The Evolution of Women in Mental Health

10.3. Current Approach to Psychotic Disorders in Mental Healthcare

10.3.1. New Studies

10.4. The Cultural Influence on the View of the Psychotic Spectrum
10.5. Internment of Psychotic Disorders

10.5.1. New Conceptualization of "Psychiatric"
10.5.2. New Voices and Ideological Proposals

10.6. The Law and Psychotic Disorders

10.6.1. Mechanical Restraint and its Peculiarities in Mental Health

10.7. New Social Policies in Mental Health and their Impact on the Psychotic Spectrum
10.8. Multidisciplinary Model in the Therapeutic Approach to Psychotic Disorders
10.9. New Perspectives and Diagnostic Approaches in the Psychotic Spectrum
10.10. Future Challenges

10.10.1. Current Lines of Research in Psychotic Disorders

You will incorporate the most disruptive approaches to the rehabilitation of patients with psychotic disorders into your professional practice in only 1,500 hours. Enroll now!”